icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Patients with HBeAg-positive chronic hepatitis B with a maintained virologic response to entecavirachieved HBsAg clearance when switched to peginterferon alfa-2a (40KD) therapy (the OSST study)
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
Q. Ning,1 M.F. Han,1 Y.T. Sun,2 J.J. Jiang,3 D.M. Tan,4 J.L. Hou,5 H. Tang,6 J.F. Sheng,7 M. Jiang8 1Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, China; 2Tangdu Hospital, the Fourth Military Medical University, China; 3The First Hospital, Fujian Medical University, China; 4Xiangya Hospital, Central South University, China; 5Nanfang Hospital, Nanfang Medical University, China; 6Huaxi Hospital, Sichuan University, China; 7The First Hospital, Zhejiang University, China; 8formerly of Roche Pharmaceutical Co. Ltd., Shanghai, China

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif